QMENTA Platform was created to meet the needs of different clinical trials and their requirements with its fully flexible and customizable infrastructure.
Investigators participating in a trial can easily upload all their medical images on our platform via our lightweight standalone desktop app. Data will be locally anonymized before transmission and will be seamlessly uploaded to our platform. Data may also be directly uploaded via web browser, where it will be transmitted to our platform through a secure encryption and anonymized on arrival.
It is also possible to aggregate data from various sources and all are seamlessly integrated, grouped, and standardized to eliminate time spent on data management.
Once uploaded, data can also be pre-processed and standardized for further processing, saving precious time. Quantitative scores can also be uploaded to the platform to accompany imaging data and have all patient data in one place.
QMENTA platform enables Principal Investigators (PIs) to easily monitor the changes and/or the progress of the disease by regularly uploading the scans and clinical test results where they are automatically grouped according to patients or healthy controls.
Various analysis pipelines help investigators to easily mine brain imaging data sets to get more detailed and quantified insight. These analytics bolster efforts in identifying new biomarkers for diagnostics by enabling PIs to easily explore correlations between changes in neuroanatomy and neurophysiology measured by our tools through clinical data and tests.
Biomarkers enable investigators to determine the stage of the disease and facilitate early and accurate diagnosis of neurological diseases. More accurate and faster diagnostics is critical to optimize the patient selection process for the clinical trial as better patient selection can increase the probabilities of success of high risk trials on neurological diseases.
Our aim is to support your rigorous R&D processes and help you successfully discover and develop more treatments for neurological disorders. The analytics of the platform also allow investigators to quantitatively measure and thus validate the efficacy of a certain treatment or drug under trial.
The cloud system supports the collaboration of various investigators and projects of single or multiple trial sites. This is made seamless with the ability to assign various fine-grained access levels to the members with one project administrator.
All investigators can securely share data, analyses, and results inside teams and between external parties of research. In multisite trials, different teams working on the same project can access and follow each other’s work and share results for comparison. All members can invite third parties to share data or collaborate.
For optimized collaboration, the owner of the data can assign different roles to members of the project: data administrator (all PIs), collaborator, guest, etc. who have different privileges.
In one specific multi-site project type – star – a coordinator is the hub with full access to collect all information and manage all aspects of the project. Various collaborators contribute to the project by uploading data, runnin analyses, sharing results, however none of them have access to other members’ data.
All data is safely stored on our platform that is HIPAA compliant. The privacy of your patient’s’ private health information (PHI) is respected at all times with automated anonymization. All patients are assigned an ID to make it easier for investigators to track the all patient data throughout the platform.
“Their unique solution in combination with the need that they are addressing in the Neuroimaging community will create a much needed standard system for the emerging era of Neuroimaging and even more broadly radio-genomics. I’ve worked with QMENTA’s team over the last year. They are an excellent team of talented, efficient and helpful individuals who’ve been proactively helping us with the data management and analysis of some of our projects.”Sarah J. Nelson, PhDProfessor, Department of Radiology and Biomedical Imaging, Director, Center for Non-Invasive Imaging and Metabolomics (CNIM) and the Surbeck Laboratory of Advanced Imaging
“This technology changes dramatically the way we understand these diseases, and help us determine which parts of the brain are not working properly. We are using these quantification tools to detect easier which brain regions are damaged and help us find better and personalized treatments for our patients.”Angels García-Cazorla, MD, PhDPrincipal Investigator, Hospital Sant Joan de Déu
“QMENTA's team develops outstanding state-of-the-art image processing tools in order to have a deeper understanding of psychiatric diseases. With their tools, I can easily manage large series of images, run analyses and dig deeper into the brain wiring and functional features of psychiatric patients.”Carles Soriano-Mas, PhDBellvitge Biomedical Research Institute - IDIBELL Psychiatry Service